Dendritic cells overexpressing FasL induce anti-tumoral T-cell response in vivo

被引:0
|
作者
Buonocore, S
Haddou, NO
Moore, F
Laporte, M
Paulart, F
Flemal, F
Thielemans, K
Goldman, M
Flamand, V
机构
[1] Inst Med Immunol, Expt Immunol Lab, Brussels, Belgium
[2] Free Univ Brussels, Erasme Hosp, Dept Dermatol, B-1050 Brussels, Belgium
[3] Vrije Univ Brussels, Physiol Lab, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [31] Induction of CD4+ T-cell responses by dendritic cells in vivo
    Suri, RM
    Kukutsch, N
    Fowler, S
    Powrie, F
    Austyn, JM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 32 - 32
  • [32] MyD88-silenced dendritic cells induce T-cell hyporesponsiveness and promote Th2 polarization in vivo
    Bao, Weilei
    Qin, Xihu
    Guan, Naifu
    Wang, Shizhong
    Zhu, Jianfei
    Sun, Xiao
    Zhou, Haijun
    Zhu, Zhichao
    Zhu, Chunfu
    CYTOTHERAPY, 2015, 17 (09) : 1240 - 1250
  • [33] DENDRITIC EPIDERMAL T-CELLS INHIBIT T-CELL PROLIFERATION AND MAY INDUCE TOLERANCE BY CYTOTOXICITY
    LOVESCHIMENTI, CD
    KRIPKE, ML
    JOURNAL OF IMMUNOLOGY, 1994, 153 (08): : 3450 - 3456
  • [34] EVALUATING THE COMPATIBILITY OF TUMOR TREATING ELECTRIC FIELDS WITH KEY ANTI-TUMORAL T CELL FUNCTIONS
    Diamant, Gl
    Simchony, Hadar
    Shiloach, Tamar
    Globerson-Levin, Anat
    Eshhar, Zelig
    Grossman, Rachel
    Ram, Zvi
    Volovitz, Ilan
    NEURO-ONCOLOGY, 2018, 20 : 137 - 138
  • [35] Induction of Specific T-Cell Response Following In Vivo Treatment of Dendritic Cells by 1,25-Dihydroxycholecalciferol
    Eftekharian, Mohammad Madhi
    Moazzeni, Seyed Mohammad
    Zarnani, Amir Hassan
    YAKHTEH, 2010, 12 (02): : 215 - 222
  • [36] In Vivo Anti-Tumoral Effects of Simvastatin in a Cancer Stem Cell-Rich Model of Breast Carcinoma
    Renno, A. L.
    De Souza, P. C.
    De Souza, V. B.
    Freitas, C. P.
    Pavanello, M.
    Franchi, G. C., Jr.
    Nowill, A. E.
    Schenka, N. G. M.
    Rocha, R. M.
    Pinto, G. A.
    Soares, F. A.
    Vassallo, J.
    Rezende, L. F.
    Schenka, A. A.
    LABORATORY INVESTIGATION, 2012, 92 : 465A - 465A
  • [37] Evaluating the compatibility of tumor treating electric fields with key anti-tumoral T cell functions
    Diamant, Gil
    Simchony, Hadar
    Shiloach, Tamar
    Globerson-levin, Anat
    Eshhar, Zelig
    Grossman, Rachel
    Ram, Zvi
    Volovitz, Ilan
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Sepsis-trained macrophages promote anti-tumoral tissue-resident T cells
    Broquet, Alexis
    Gourain, Victor
    Goronflot, Thomas
    Le Mabecque, Virginie
    Debajyoti, Sihna
    Cedric, Jacqueline
    Ashayeripanah, Mitra
    Martin, Pierre
    Davieau, Marion
    Boutin, Lea
    Poulain, Cecile
    Martin, Florian P.
    Fourgeux, Cynthia
    Petrier, Melanie
    Guillonneau, Maeva
    Legenti, Laurent
    Ferrieres, Vincent
    Mami-Chouaib, Fathia
    Mosnier, Jean Francois
    Mauduit, Nicolas
    McWilliam, Hamish
    Villadangos, Jose
    Gourraud, Pierre Antoine
    Poschmann, Jeremie
    Roquilly, Antoine
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 27 - 27
  • [39] Dendritic Cells in Shaping Anti-Tumor T Cell Response
    Mazzoccoli, Luciano
    Liu, Bei
    CANCERS, 2024, 16 (12)
  • [40] In Vivo Anti-Tumoral Effects of Simvastatin in a Cancer Stem Cell-Rich Model of Breast Carcinoma
    Renno, A. L.
    De Souza, P. C.
    De Souza, V. B.
    Freitas, C. P.
    Pavanello, M.
    Franchi, G. C., Jr.
    Nowill, A. E.
    Schenka, N. G. M.
    Rocha, R. M.
    Pinto, G. A.
    Soares, F. A.
    Vassallo, J.
    Rezende, L. F.
    Schenka, A. A.
    MODERN PATHOLOGY, 2012, 25 : 465A - 465A